Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?

Cancer Genetics and Cytogenetics

Volumn 151, Issue 2, 2004, Pages 139-145

  Zamora, Lurdes ^a,b   Espinet, Blanca ^a,c   Florensa, Lourdes ^a,c   Besses, Carles ^a   Woessner, Soledad ^c   Serrano, Sergi ^a   Solé, Francesc ^a,c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Laboratori de Citol Hematologica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL CULTURE; CENTROMERE; CHROMOSOME 13Q; CHROMOSOME 20Q; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MOLECULAR PROBE; POLYCYTHEMIA VERA; PRIORITY JOURNAL;

FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; POLYCYTHEMIA VERA;

EID: 2542468674     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.09.011     Document Type: Article

References (44)

1. Berlin N.I. Diagnosis and classification of the polycythemias. Semin Hematol. 12:1975;339-351
2. Pearson T.C. Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol. 38:(suppl 2):2001;21-24
3. Dewald G.W., Wright P.I. Chromosome abnormalities in the myeloproliferative disorders. Semin Oncol. 22:1995;341-354
4. Koulischer L., Frühling J., Henry J. Cytogenetic findings in Vaquez' disease. [in French] Eur J Cancer. 3:1967;193-201
5. Nagy G., Yurgutis R.P. Chromosome studies on patients with polycythemia vera. Haematologia. 2:1968;179-186
6. Barnes C.A., Holmes H.L., Ilbery P.L.T. Chromosome aberrations following radiophosphorus treatment of polycythemia. Australas Radiol. 13:1969;396-417
7. Lawler S.D., Millard R.E., Kay H.E.M. Further cytogenetical investigations in polycythemia vera. Eur J Cancer. 6:1970;223-233
8. Rowley J.D. Acquired trisomy 9. Lancet. 2:(7825):1973;390
9. Visfeldt J., Franzén S., Nielsen A., Tribukait B. Primary polycythemia 3. Studies of the significance of the history of the disease and of the treatment for the development of clones in bone marrow cells. Acta Pathol Microbiol Scand. 81:1973;195-203
10. Berger R., Parmentier C., Droz J.P. Karyotype studies in primary polycythemia vera. [in French] Nouv Rev Fr Hematol. 14:1974;705-712
11. Shiraishi Y., Hayata I., Sakurai M., Sandberg A.A. Chromosomes and causation of human cancer and leukemia XII. Banding analysis of abnormal chromosomes in polycythemia vera. Cancer. 36:1975;199-202
12. Gras L., Cowling D.C., Sullivan J., Hurley T.H. Unusual chromosomal changes in polycythemia vera. Med J Aust. 1:1975;37-38
13. Wurster-Hill D., Whang-Peng J., McIntyre O.R., Hsu L.Y.F., Hirschhorn K., Modan B., Pisciotta A.V., Pierre R., Balcerzak S.P., Murphy S., Weinfeld A. Cytogenetic studies in polycythemia vera. Semin Hematol. 13:1976;13-32
14. Westin J., Wahlström J., Swolin B. Chromosome studies in untreated polycythaemia vera. Scand J Haematol. 17:1976;183-196
15. Rege-Cambrin G., Mecucci C., Tricot G., Michaux J.L., Louwagie A., Van Hove W., Francart H., Van den Berghe H. A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet. 25:1987;233-245
16. Diez-Martin J.L., Graham D.L., Petitt R.M., Dewald G.W. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 66:1991;287-299
17. Najfeld V., Montella L., Scalise A., Fruchtman S. Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected. Br J Haematol. 119:2002;558-566
18. Swolin B., Weinfeld A., Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood. 72:1988;386-395
19. Bench A.J., Cross N.C., Huntly B.J., Nacheva E.P., Green A.R. Myeloproliferative disorders. [Review] Best Pract Res Clin Haematol. 14:2001;531-551
20. An international system for human cytogenetic nomenclature. Mitelman F. 1995;S. Karger, Basel
21. Pearson T.C. Diagnosis and classification of erythrocytoses and thrombocytoses. [Review] Baillieres Clin Haematol. 11:1998;695-720
22. Bench A.J., Nacheva E.P., Champion K.M., Green A.R. Molecular genetics and cytogenetics of myeloproliferative disorders. [Review] Baillieres Clin Haematol. 11:1998;819-848
23. Amiel A., Gaber E., Manor Y., Fejgin M., Joseph-Lerner N., Ravid M., Lishner M. Fluorescence in situ hybridization for the detection of trisomies 8 and 9 in polycythemia vera. Cancer Genet Cytogenet. 79:1995;153-156
24. Westwood N.B., Gruszka-Westwood A.M., Pearson C.E., Delord C.F., Green A.R., Huntly B.J., Lakhani A., McMullin M.F., Pearson T.C. The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization. Br J Haematol. 110:2000;839-846
25. Raynaud S., Cave H., Baens M., Bastard C., Cacheux V., Grosgeorge J., Guidal-Giroux C., Guo C., Vilmer E., Marynen P., Grandchamp B. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood. 87:1996;2891-2899
26. Kempski H.M., Sturt N.T. The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood. Leuk Lymphoma. 40:2000;39-47
27. Sinclair P.B., Nacheva E.P., Leversha M., Telford N., Chang J., Reid A., Bench A., Champion K., Huntly B., Green A.R. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood. 95:2000;738-743
28. Huntly B.J., Reid A.G., Bench A.J., Campbell L.J., Telford N., Shepherd P., Szer J., Prince H.M., Turner P., Grace C., Nacheva E.P., Green A.R. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood. 98:2001;1732-1738
29. Dewald G.W., Schad C.R., Lilla V.C., Jalal S.M. Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3, 996 patients with malignant hematologic neoplasms. Cancer Genet Cytogenet. 68:1993;60-69
30. Fenaux P., Morel P., Lai J.L. Cytogenetics of myelodysplastic syndromes. Semin Hematol. 33:1996;127-138
31. Solé F., Espinet B., Sanz G.F., Cervera J., Calasanz M.J., Luno E., Prieto F., Granada I., Hernandez J.M., Cigudosa J.C., Diez J.L., Bureo E., Marques M.L., Arranz E., Rios R., Martinez Climent J.A., Vallespi T., Florensa L., Woessner S. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Br J Haematol. 108:2000;346-356
32. Heim S., Mitelman F. Cytogenetic analysis in the diagnosis of acute leukemia. Cancer. 70:1992;1701-1709
33. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet. 15:1997;417-474
34. Davis M.P., Dewald G.W., Pierre R.V., Hoagland H.C. Hematologic manifestations associated with deletions of the long arm of chromosome 20. Cancer Genet Cytogenet. 12:1984;63-71
35. Campbell L.J., Garson O.M. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia. 8:1994;67-71
36. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088. [Erratum: Blood 1998;91:1100.]
37. Wattel E., Lai J.L., Hebbar M., Preudhomme C., Grahek D., Morel P., Bauters F., Fenaux P. De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features? Leuk Res. 17:1993;921-926
38. El Kassar N., Hetet G., Li Y., Briere J., Grandchamp B. Clonal analysis of haemopoietic cells in essential thrombocythaemia. Br J Haematol. 90:1995;131-137
39. Champion K.M., Gilbert J.G.R., Asimakopoulos F.A., Hinshelwood S., Green A.R. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 97:1997;920-926
40. Lucas G.S., Padua R.A., Masters G.S., Oscier D.G., Jacobs A. The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease. Br J Haematol. 72:1989;530-533
41. Gilliland D.G., Blanchard K.L., Levy J., Perrin S., Bunn H.F. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A. 88:1991;6848-6852
42. Liu E., Jelinek J., Pastore Y.D., Guan Y., Prchal J.F., Prchal J.T. Discrimination of polycythemias and thrombocytoses by novel, simple accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 101:2003;3294-3301. [electronic publication http://www.bloodjournal.org2002: DOI 10.1182/blood-2002-07-2287]
43. Temerinac S., Klippel S., Strunck E., Röder S., Lübbert M., Lange W., Azemar M., Meinhardt G., Schaefer H.E., Pahl H.L. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood. 95:2000;2569-2576
44. Teofili L., Martini M., Luongo M., Di Mario A., Leone G., De Stefano V., Larocca L.M. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. Blood. 20:2002;4249-4254